Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum REST4 as a Predictive Biomarker for Abdominal Aortic Aneurysm Progression

NCT07056491 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT07056491
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07056491 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum REST4 as a Predictive Biomarker for Abdominal Aortic Aneurysm Progression
Lead sponsor
RenJi Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
July 1, 2025
Completion date
July 1, 2031
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal aortic aneurysm